See What HealthDay Can Do For You
Contact Us

Medicare to Cover Lung Cancer CT Screening for Long-Time Smokers

Private insurers will also be required to cover screenings starting in 2015

Medicare to Cover Lung Cancer CT Screening for Long-Time Smokers

TUESDAY, Nov. 11, 2014 (HealthDay News) -- Annual lung cancer screenings for long-term smokers may soon be covered by Medicare, the U.S. Centers for Medicare & Medicaid Services announced Monday.

The reimbursement proposal would cover annual computed tomography (CT) scans for people aged 55 to 74 with a smoking history of 30 pack-years who still smoke or who quit within the last 15 years. Medicare will require people to undergo smoking cessation counseling or counseling on the importance of staying smoke-free prior to receiving the annual scan. The agency will also require the following: (1) participating radiologists have solid experience in reading and interpreting CT scans for possible lung cancer; (2) the CT scans occur at a radiology imaging center with experience in lung cancer screening or accreditation as an advanced diagnostic imaging center; and (3) participating centers submit data on all CT screening findings, follow-up, and patient outcomes.

Private insurers will also be required to cover lung cancer screenings for this group of people starting in 2015, the result of a recommendation issued almost a year ago by the U.S. Preventive Services Task Force.

The public will be allowed to submit comments to Medicare in response to the proposal until Dec. 10. A final announcement is expected next February, at which time coverage for Medicare beneficiaries will begin, according to the American Lung Association.

Full Article
More Information

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.